Prognostic nutritional index as a novel marker for diabetic retinopathy in individuals with type 2 diabetes mellitus

Basit Öğe Kaydı
dc.contributor.authorKurtul, Bengi E.
dc.contributor.authorKoca, Suleyman
dc.contributor.authorYilmaz, Muge O.
dc.date.accessioned2024-09-18T19:52:33Z
dc.date.available2024-09-18T19:52:33Z
dc.date.issued2022
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractPURPOSE: In recent years, the prognostic nutritional index (PNI), an easily obtainable nutritional inflammatory marker, has been introduced as an independent prognostic indicator for various types of cancers and cardiovascular diseases. However, its clinical importance in the area of ophthalmology is not well known yet. We aimed to elucidate the association between the PNI and the occurrence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). METHODS: In this cross-sectional study, the PNI was applied to 128 consecutive patients with T2DM. The relationship between the PNI and the occurrence of DR was examined. PNI was calculated as 10x (serum albumin) + 0.005 x (total lymphocyte count). The risk factors for DR were evaluated using multivariate logistic regression analysis. A receiver operating characteristic (ROC) curve analysis of PNI for predicting DR was performed. RESULTS: Patients with DR had significantly lower levels of PNI than those without DR (41.20 +/- 4.81 and 44.49 +/- 3.10, respectively, P < 0.001). Multivariate regression analysis indicated that PNI, together with the duration of diabetes and creatinine, was an independent factor for DR occurrence (odds ratio, 0.885; 95% confidence interval: 0.735-0.971; P = 0.017). ROC curve analysis revealed that the best cutoff value of PNI was 43 (area under the curve: 0.713; sensitivity: 74%; specificity: 64%). CONCLUSION: A lower PNI value is common among T2DM patients with DR and is strongly associated with the occurrence of DR. The PNI might be a useful biomarker for identifying DR to improve the risk stratification and management of T2DM patients.en_US
dc.identifier.doi10.4103/sjopt.sjopt_63_22
dc.identifier.endpage326en_US
dc.identifier.issn1319-4534
dc.identifier.issn2542-6680
dc.identifier.issue3en_US
dc.identifier.pmid36276247en_US
dc.identifier.scopus2-s2.0-85140969465en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage322en_US
dc.identifier.urihttps://doi.org/10.4103/sjopt.sjopt_63_22
dc.identifier.urihttps://hdl.handle.net/20.500.12483/7511
dc.identifier.volume36en_US
dc.identifier.wosWOS:000876476600012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofSaudi Journal of Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAlbuminen_US
dc.subjectbiomarkeren_US
dc.subjectdiabetic retinopathyen_US
dc.subjectlymphocyteen_US
dc.subjectprognostic nutritional indexen_US
dc.subjecttype 2 diabetes mellitusen_US
dc.titlePrognostic nutritional index as a novel marker for diabetic retinopathy in individuals with type 2 diabetes mellitusen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
7511.pdf
Boyut:
610.39 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu